“WCG’s eCOA expertise and capabilities in subjective endpoints are a strategic and complementary fit with Clario’s endpoint solutions. This transaction allows WCG to focus on being a trusted partner in connecting sponsors and CROs with sites to accelerate trials through trial design, study review, site activation, and participant ...

2 days ago · The WCG move bolsters Clario’s eCOA services, which already include a digital multimedia platform built on the firm’s 25 years of experience in the field, according to Clario.

3 days ago · WCG CEO Sam Srivastava said: “WCG’s eCOA expertise and capabilities in subjective endpoints are a strategic and complementary fit with Clario’s endpoint solutions. This transaction allows WCG to focus on being a trusted partner in connecting sponsors and CROs with sites to accelerate trials through trial design, study review, site ...

5 days ago · Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials Clario publishes third annual ESG Report, reaffirms commitment to ethical AI, workforce investment, and sustainability targets

4 days ago · Clario’s shareholders are Astorg, Nordic Capital, Novo Holdings, and Cinven. Headquartered in Princeton, New Jersey, WCG is a provider of solutions that measurably improve and accelerate ...

5 days ago · Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in ...

Discover Clario's AI solutions, where innovation meets expertise. Since 2018, we have revolutionized clinical trial endpoint analyses with more than 30 AI-enabled solutions across 600+ active trials, enhancing data quality and patient privacy while expediting data collection processes.

5 days ago · Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced they have entered into a definitive agreement to acquire the eCOA business of WCG, a leader in providing solutions that measurably improve and accelerate clinical research.. Electronic clinical outcomes assessments (eCOA), in addition to paper assessments, are used to evaluate the safety and ...

4 days ago · Acquisition of WCG's electronic clinical outcome assessments (eCOA) business will expand Clario's scientific expertise and offerings in neuroscience

1 day ago · La empresa tecnológica Clario ha fortalecido su presencia en el sector de la evaluación electrónica de resultados clínicos (eCOA) con la adquisición del negocio de neurociencia de WCG, especializado en neurología, psiquiatría, dolor neuropático y enfermedades raras.Este movimiento estratégico, anunciado el 10 de marzo, busca ampliar las capacidades de Clario en el ámbito de la ...